Analyst stock forecast
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Stock Forecast and Analyst Price Target
SVA analyst target range, upside, consensus rating and coverage count.
Direct answer
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s average price target is $3.52.
The target implies -45.6% from the recorded current price, and the consensus rating is Buy.
The verified range is $1.50 to $6.00, with 6 analysts in the current consensus when available.
Forecast evidence checked August 12, 2026.
Get free Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $6.47
- Average price target
- $3.52
- High price target
- $6.00
- Low price target
- $1.50
- Target upside
- -45.6%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 12, 2026
- Valid through
- August 19, 2026
Explore related company data
View Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s price target rangeView Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s target upside or downsideView Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo)'s analyst consensus ratingReturn to Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) profile